A2A Pharmaceuticals, Inc.

CIK 1859061 · last filed 2023-06-02

A2A Pharmaceuticals, Inc. is a corporate insider who has filed 13 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $4.3M of BMEA on Jun 2, 2023. Across all open-market trades the lifetime net is −$20.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$4.44M

Companies

1

Total Filings

13

Lifetime Open-Market Net

-$20.35M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
BMEA	10%+ Owner	3,550,000	$1.25	$4.44M	-$20.35M	10	2023-06-02

Recent Filings

13 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-06-02	BMEA	Sell (S)	−125,000	-$4.26M	EDGAR
2023-05-19	BMEA	Notice (144)	−1,500,000	-$48.20M	EDGAR
2023-05-17	BMEA	Sell (S)	−25,000	-$846.0K	EDGAR
2023-05-10	BMEA	Sell (S)	−250,000	-$8.58M	EDGAR
2023-04-27	BMEA	Notice (144)	−400,000	-$12.00M	EDGAR
2023-04-26	BMEA	Sell (S)	−200,000	-$5.82M	EDGAR
2023-04-20	BMEA	Notice (144)	−200,000	-$5.55M	EDGAR
2023-04-06	BMEA	Sell (S)	−200,000	-$6.25M	EDGAR
2023-04-06	BMEA	Sell (S)	+200,000	$6.25M	EDGAR
2022-08-19	BMEA	Buy (P)	−30,684	-$425.6K	EDGAR

Showing 1–10 of 13

Page 1 of 2 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.